In a bid to overcome the Covid-19 pandemic, various countries in the world have started to roll-out different types of Covid-19 vaccines to their respective populations. In several high income-countries, vaccines are rolled-out free of charge. However, in the case of low-income countries, economic limitations and weak health systems do not permit full scale free vaccination. This brings forward the inevitable option of out-of-pocket payment for vaccine by part, if not all, of the population. Moreover, low-income countries are lagging behind in their vaccination campaigns, and evidence on vaccine acceptance and willingness to pay, crucial public health planning inputs, remains scant. The participants of the roundtable presented evidence on potential determinants of willingness to take and pay for Covid-19 vaccine in some low-income countries and discussed potential implications for policy makers.

Speakers

• Emmanuel Rukondo, University Bonn
• Britta Augsburg, Institute for Fiscal Studies (IFS)
• Christoph Strupat, German Development Instiute / Deutsches Institut für Entwicklungspolitik (DIE)